WHO ICTRP trial
Diagnostic and Patient Management Study
EUCTR2017-002527-21-DE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-002527-21-DE |
|---|---|
| Public title | Diagnostic and Patient Management Study |
| Scientific title | Multicentre, Open-label, Randomised Study to Assess the Diagnostic Value of Amyloid PET Imaging in Patients with Subjective Cognitive Decline Plus, Mild Cognitive Impairment, or Dementia Where Alzheimer’s Disease is in the Differential Diagnosis - DPMS |
| Primary sponsor | University of Geneva |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | European Union;Spain;Netherlands;Germany;Switzerland |
| Conditions | Alzheimer's disease Mild Cognitive Impairment Subjective Cognitive Decline Plus;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01] |
| Interventions | Trade Name: Neuraceq Product Name: Neuraceq Pharmaceutical Form: Solution for injection INN or Proposed INN: Florbetaben CAS Number: 902143-01-5 Other descriptive name: FLORBETABEN (18F) Concentration unit: MBq/ml… |
| Registration date | Apr 24, 2018 |
| Target size | 900 |
| Secondary IDs | AMYPAD-01;2017-002527-21-NL |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: